Life Sciences & Medicine Active Updated Sep 2, 2026
NIH antibodies found to block a tick-bite meat allergy
NIH researchers isolated 42 antibodies from malaria-exposed people while trying to fight the parasite, then found several bound and blocked the allergens behind alpha-gal syndrome, a tick-bite allergy with no treatment beyond meat avoidance. The stakes are whether this laboratory lead can become an actual therapy for the roughly 110,000 documented US cases.
The story so far
-
Sep 2, 2026 Latest
NIH scientists screened 42 antibodies originally isolated to fight malaria against alpha-gal syndrome allergens and found 13 bound the allergens, two blocked patients' own allergic antibodies from attaching, and a third stopped basophils from activating, a first biological lead beyond meat avoidance for a tick-bite allergy with roughly 110,000 documented US cases.
This story moves with the morning letter.
When this arc advances, the timeline above grows the same morning. One short, warm letter with the day's real progress in science, medicine and beyond. Free, every day.
Free forever, no spam. One click to unsubscribe, and we never sell your email.